Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV-2 infection. We profiled MIS-C, adult COVID-19, and healthy pediatric and adult individuals using single-cell RNA sequencing, flow cytometry, antigen receptor repertoire analysis, and unbiased serum proteomics, which collectively identified a signature in MIS-C patients that correlated with disease severity. Despite having no evidence of active infection, MIS-C patients had elevated S100A-family alarmins and decreased antigen presentation signatures, indicative of myeloid dysfunction. MIS-C patients showed elevated expression of cytotoxicity genes in NK and CD8+ T cells and expansion of specific IgG-expressing plasmablasts. Clinically severe MIS-C patients displayed skewed memory T cell TCR repertoires and autoimmunity characterized by endothelium-reactive IgG. The alarmin, cytotoxicity, TCR repertoire, and plasmablast signatures we defined have potential for application in the clinic to better diagnose and potentially predict disease severity early in the course of MIS-C.
Full Text
Topics from this Paper
Full Text PDF PubMed Scopus
PubMed Scopus
Multisystem Inflammatory Syndrome In Children
Multisystem Inflammatory Syndrome
Google Scholar
+ Show 5 more
Create a personalized feed of these topics
Get StartedTalk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
The Journal of Pediatrics
Sep 1, 2020
Cell
Nov 1, 2020
The Journal of Pediatrics
Jun 1, 2021
The Journal of Pediatrics
Sep 1, 2020
The Lancet Rheumatology
Mar 1, 2021
American Journal of Transplantation
Jul 1, 2021
The Lancet Diabetes & Endocrinology
Dec 1, 2020
Kidney International
Jul 1, 2021
Journal of the Neurological Sciences
Nov 1, 2020
The Lancet Child & Adolescent Health
Jun 1, 2022
Clinical Nutrition ESPEN
Jun 1, 2022
The Lancet Infectious Diseases
Jun 1, 2021
Journal of the American Society of Echocardiography
Oct 1, 2020
The Innovation
Sep 1, 2022
Gastroenterology
Apr 1, 2021
Immunity
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023
Immunity
Nov 1, 2023